Sound Income Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
5,071
+2,604
+106% +$150K 0.01% 382
2026
Q1
$152K Sell
2,467
-605
-20% -$35.3K 0.01% 487
2025
Q4
$170K Buy
3,072
+171
+6% +$8.23K 0.01% 462
2025
Q3
$130K Buy
2,901
+302
+12% +$14.1K 0.01% 357
2025
Q2
$120K Sell
2,599
-3,751
-59% -$184K 0.01% 356
2025
Q1
$387K Buy
6,350
+336
+6% +$19.6K 0.02% 205
2024
Q4
$340K Buy
6,014
+3,244
+117% +$181K 0.02% 190
2024
Q3
$143K Buy
2,770
+885
+47% +$41.5K 0.01% 290
2024
Q2
$78.3K Buy
1,885
+255
+16% +$11.4K ﹤0.01% 373
2024
Q1
$88.4K Sell
1,630
-9
-0.5% -$458 0.01% 333
2023
Q4
$84.1K Buy
1,639
+672
+69% +$35.3K 0.01% 313
2023
Q3
$56.1K Buy
967
+148
+18% +$9.07K ﹤0.01% 294
2023
Q2
$52.4K Sell
819
-700
-46% -$46.9K 0.01% 296
2023
Q1
$105K Sell
1,519
-287
-16% -$20.2K 0.01% 195
2022
Q4
$130K Buy
1,806
+253
+16% +$19.1K 0.02% 168
2022
Q3
$110K Buy
1,553
+16
+1% +$1.16K 0.02% 167
2022
Q2
$118K Hold
1,537
0.02% 160
2022
Q1
$112K Sell
1,537
-104
-6% -$6.98K 0.01% 163
2021
Q4
$102K Sell
1,641
-26
-2% -$1.52K 0.01% 174
2021
Q3
$99K Buy
1,667
+2
+0.1% +$132 0.01% 171
2021
Q2
$111K Sell
1,665
-9
-0.5% -$587 0.02% 166
2021
Q1
$106K Buy
1,674
+130
+8% +$8.09K 0.02% 168
2020
Q4
$96K Buy
1,544
+2
+0.1% +$123 0.02% 153
2020
Q3
$93K Buy
1,542
+2
+0.1% +$120 0.03% 130
2020
Q2
$91K Buy
1,540
+84
+6% +$5.02K 0.03% 110
2020
Q1
$81K Buy
1,456
+1,351
+1,287% +$82.6K 0.03% 95
2019
Q4
$7K Hold
105
﹤0.01% 389
2019
Q3
$5K Hold
105
﹤0.01% 411
2019
Q2
$5K Sell
105
-150
-59% -$6.99K ﹤0.01% 431
2019
Q1
$12K Hold
255
0.01% 301
2018
Q4
$13K Hold
255
0.01% 285
2018
Q3
$16K Sell
255
-5
-2% -$297 0.01% 267
2018
Q2
$14K Buy
260
+5
+2% +$270 0.01% 256
2018
Q1
$16K Hold
255
0.01% 222
2017
Q4
$16K Buy
+255
New +$15.9K 0.01% 159

Other funds holding BMY

Sound Income Strategies's BMY Position: Q2 2026 in Review

Sound Income Strategies increased its Bristol-Myers Squibb (BMY) stake by 106% in Q2 2026, buying an estimated $150K and bringing the position to 5,071 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #382.

Sound Income Strategies first reported a position in BMY in Q4 2017 and has held it in 35 quarters since. The position peaked at $387K in Q1 2025. 1,229 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sound Income Strategies held 5,071 shares of Bristol-Myers Squibb worth $292K as of Q2 2026.
  • Sound Income Strategies bought 2,604 Bristol-Myers Squibb shares in Q2 2026, an estimated $150K.
  • Bristol-Myers Squibb made up 0.01% of Sound Income Strategies's portfolio in Q2 2026, its #382 holding.
  • Sound Income Strategies first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 35 quarters since.
  • Sound Income Strategies's Bristol-Myers Squibb position peaked at $387K in Q1 2025.
  • 1,229 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.